Lymphedema in breast cancer survivors: Incidence, degree, time course, treatment, and symptoms

Journal of Clinical Oncology

Volumn 27, Issue 3, 2009, Pages 390-397

  Norman, Sandra A ^a   Localio, A Russell ^a   Potashnik, Sheryl L ^a   Torpey, Heather A Simoes ^a   Kallan, Michael J ^a   Weber, Anita L ^a   Miller, Linda T ^a   Demichele, Angela ^a   Solin, Lawrence J ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER INCIDENCE; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; FEMALE; HUMAN; LYMPHEDEMA; MAJOR CLINICAL STUDY; PHYSIOTHERAPIST; PRIORITY JOURNAL; QUESTIONNAIRE; RATING SCALE; SYMPTOM;

AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; FEMALE; HUMANS; LYMPHEDEMA; MIDDLE AGED; PROSPECTIVE STUDIES; QUESTIONNAIRES; RANDOM ALLOCATION;

EID: 58549088156     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2008.17.9291     Document Type: Article

References (39)

1. Passik SD, McDonald MV: Psychosocial aspects of upper extremity lymphedema in women treated for breast carcinoma. Cancer 83:2817-2820, 1998
2. Passik S, Newman M, Brennan M, et al: Psychiatric consultation for women undergoing rehabilitation for upper-extremity lymphedema following breast cancer treatment. J Pain Symptom Manage 8:226-233, 1993
3. Tobin MB, Lacey HJ, Meyer L, et al: The psychological morbidity of breast cancer-related arm swelling: Psychological morbidity of lymphoedema. Cancer 72:3248-3252, 1993
4. McWayne J, Heiney SP: Psychologic and social sequelae of secondary lymphedema. Cancer 104:457-466, 2005
5. Kuehn T, Klauss W, Darsow M, et al: Long-term morbidity following axillary dissection in breast cancer patients: Clinical assessment, significance for life quality and the impact of demographic, oncologic and therapeutic factors. Breast Cancer Res Treat 64:275-286, 2000
6. American Cancer Society: Lymphedema: Understanding and Managing Lymphedema After Cancer Treatment. Atlanta, GA, American Cancer Society, 2006
7. Norman SA, Miller LT, Erikson HB, et al: Development and validation of a telephone questionnaire to characterize lymphedema in women treated for breast cancer. Phys Ther 81:1192-1205, 2001
8. Petrek JA, Heelan MC: Incidence of breast carcinoma-related lymphedema. Cancer 83:2776-2781, 1998
9. Petrek J, Pressman P, Smith R: Lymphedema: Current issues in research and management. CA Cancer J Clin 50:292-307, 2000
10. Williams A, Franks P, Moffatt C: Lymphoe-dema: Estimating the size of the problem. Palliat Med 19:300-313, 2005
11. Clark B, Sitzia J, Harlow W: Incidence and risk of arm oedema following treatment for breast cancer: A three-year follow-up study. QJM 98:343-348, 2005
12. Engel J, Kerr J, Schlesinger-Raab A, et al: Axilla surgery severely affects quality of life: Results of a 5-year prospective study in breast cancer patients. Breast Cancer Res Treat 79:47-57, 2003
13. Herd-Smith A, Russo A, Muraca MG, et al: Prognostic factors for lymphedema after primary treatment for breast carcinoma. Cancer 92:1783-1787, 2001
14. Mansel R, Fallowfield L, Kissin M, et al: Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: The ALMANAC trial. J Natl Cancer Inst 98:599-609, 2006
15. Fleissig A, Fallowfield LJ, Langridge CI, et al: Post-operative arm morbidity and quality of life: Results of the ALMANAC randomised trial comparing sentinel node biopsy with standard axillary treatment in the management of patients with early breast cancer. Breast Cancer Res Treat 95:279-293, 2006
16. Paskett ED, Naughton MJ, McCoy TP, et al: The epidemiology of arm and hand swelling in premenopausal breast cancer survivors. Cancer Epidemiol Biomarkers Prev 16:775-782, 2007
17. Geller B, Vacek P, O'Brien P, et al: Factors associated with arm swelling after breast cancer surgery. J Womens Health 12:921-930, 2003
18. Francis W, Abghari P, Du W, et al: Improving surgical outcomes: Standardizing the reporting of incidence and severity of acute lymphedema after sentinel lymph node biopsy and axillary lymph node dissection. Am J Surg 192:636-639, 2006
19. Armer J, Radina M, Porock D, et al: Predicting breast cancer-related lymphedema using self-reported symptoms. Nurs Res 52:370-379, 2003
20. Hull M: Lymphedema in women treated for breast cancer. Semin Oncol Nurs 16:226-237, 2000
21. Gerber LH: A review of measures of lymphedema. Cancer 83:2803-2804, 1998
22. Erickson VS, Pearson ML, Ganz PA, et al: Arm edema in breast cancer patients. J Natl Cancer Inst 93:96-111, 2001
23. Petrek J, Pressman P, Smith R: Lymphedema: Results from a workshop on breast cancer treatment-related lymphedema and lymphedema resource guide. Cancer 83:2775-2890, 1998
24. Rockson SG, Miller LT, Senie R: Diagnosis and management of lymphedema. Cancer 83:2882-2885, 1998
25. Armer J: The problem of post-breast cancer lymphedema: Impact and measurement issues. Cancer Invest 23:76-83, 2005
26. Goffman T, Laronga C, Wilson L, et al: Lymphedema of the arm and breast in irradiated breast cancer patients: Risks in an era of dramatically changing axillary surgery. Breast J 10:405-411, 2004
27. Blanchard D, Donohue J, Reynolds C, et al: Relapse and morbidity in patients undergoing sentinel lymph node biopsy alone or with axillary dissection for breast cancer. Arch Surg 138:482-487, 2003
28. Swenson K, Nissen M, Ceronsky C, et al: Comparison of side effects between sentinel lymph node and axillary lymph node dissection for breast cancer. Ann Surg Oncol 9:745-753, 2002
29. Schijven M, Vingerhoets A, Rutten H, et al: Comparison of morbidity between axillary lymph node dissection and sentinel node biopsy. EJSO 29:341-350, 2003
30. Portenoy RK, Thaler HT, Kornblith AB, et al: The Memorial Symptom Assessment Scale: An instrument for the evaluation of symptom prevalence, characteristics and distress. Eur J Cancer 30A:1326-1336, 1994
31. Kleinbaum DG, Kupper LL, Morgenstern H: Epidemiologic Research. Belmont, CA, Lifetime Learning Publications, 1982
32. Kalbfleisch JD, Prentice RL: The Statistical Analysis of Failure Time Data. New York, NY, John Wiley and Sons, 1980
33. Bull K, Spiegelhalter D: Survival analysis in observational studies. Stat Med 16:1041-1074, 1997
34. Pennsylvania Department of Health: Cancer incidence 1990-2005: Cancer cases by 23 sites for Pennsylvania and by county by sex, race and age. Harrisburg, PA, Pennsylvania Department of Health, 2008
35. Haid A, Kuehn T, Konstantiniuk P, et al: Shoulder-arm morbidity following axillary dissection and sentinel node only biopsy for breast cancer. EJSO 28:705-710, 2002
36. Schrenk P, Rieger R, Shamiyeh A, et al: Morbidity following sentinel lymph node biopsy versus axillary lymph node dissection for patients with breast carcinoma. Cancer 88:608-614, 2000
37. Mortimer P, Bates D, Brassington H, et al: The prevalence of arm oedema following treatment for breast cancer. QJM 89:377-380, 1996
38. Powell S, Taghian A, Kachnic L, et al: Risk of lymphedema after regional nodal irradiation with breast conservation therapy. Int J Radiat Oncol Biol Phys 55:1209-1215, 2003
39. Schünemann H, Willich N: Lymphoedema of the arm after primary treatment of breast cancer. Anticancer Res 18:2235-2236, 1998